本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acurx Pharmaceuticals, LLC*

3.45
-0.0500-1.43%
盘后3.450.00000.00%19:03 EST
成交量:3.37万
成交额:11.69万
市值:718.05万
市盈率:-0.33
高:3.55
开:3.55
低:3.40
收:3.50
52周最高:25.00
52周最低:3.17
股本:208.13万
流通股本:180.82万
量比:0.82
换手率:1.87%
股息:- -
股息率:- -
每股收益(TTM):-10.3664
每股收益(LYR):-17.4507
净资产收益率:-291.07%
总资产收益率:-95.64%
市净率:1.97
市盈率(LYR):-0.20

数据加载中...

2025/03/17

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/10

重要事件披露

Form 8-K - Current report
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/04

SEC问询函

Form CORRESP - Correspondence
2025/01/31

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/01/07

重要事件披露

Form 8-K - Current report
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/09

重要事件披露

Form 8-K - Current report
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/06/18

重要事件披露

Form 8-K - Current report
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/15

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/04/02

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2024/03/29

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2024/03/18

重要事件披露

Form 8-K - Current report
2024/03/18

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/15

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]